EX-5.1 3 ex51.htm OPINION ON LEGALITY Blueprint
EXHIBIT 5.1 
Intellipharmaceutics International Inc.
30 Worcester Road
Toronto, Ontario
Canada M9W 5X2
 
September 20, 2018
 
 
Re:          IntelliPharmaCeutics International Inc. – Registration Statement on Form F-1
 
Ladies and Gentlemen:
 
We have acted as Canadian corporate counsel to IntelliPharmaCeutics International Inc. (the “Company”), a corporation formed under the federal laws of Canada, in connection with the preparation of the registration statement of the Company on Form F-1 (the “Registration Statement”) filed today by the Company with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Act”), including the form of prospectus contained therein (the “Prospectus”).
 
The Registration Statement relates to the offering and sale by the Company of up to US$15,000,000 of (A) units (the “Units”), each Unit comprised of: (i) one common share of the Company (the “Unit Shares”); and (ii) one common share purchase warrant (a “Warrant”), each Warrant being exercisable to purchase one common share of the Company (a “Warrant Share”); and (B) pre-funded units (the “Pre-Funded Units”), each Pre-Funded Unit comprised of: (i) one pre-funded common share purchase warrant (a “Pre-Funded Warrant”), each Pre-Funded Warrant being exercisable to purchase one common share of the Company (a “Pre-Funded Warrant Share”) at an exercise price of USD$0.01 per Pre-Funded Warrant Share (subject to adjustment); and (ii) one Warrant.
 
In addition, the Registration Statement relates to the issue of common share purchase warrants (the “Wainwright Warrants”), each Wainwright Warrant being exercisable to purchase one common share of the Company (a “Wainwright Warrant Share”) in an aggregate amount of up to US$1,125,000.
 
The Unit Shares, Warrants, Warrant Shares, Pre-Funded Warrants, Pre-Funded Warrant Shares, Wainwright Warrants and Wainwright Warrant Shares are collectively referred to herein as the “Offered Securities”. No opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or the Prospectus, other than as expressly stated herein with respect to the issuance of the Offered Securities.
 
Examination of Documents
 
In giving the opinions expressed below we have examined originals or copies, certified or otherwise identified to our satisfaction, of such corporate and other records and documents as we considered appropriate including, without limitation:
 
(a)            
the articles of the Company, as amended and currently in effect;
 
(b)            
the by-laws of the Company, as currently in effect;
 
(c) 
a certificate of an officer of the Company as to certain matters of fact (the “Officer’s Certificate”); and
 
(d) 
certified written resolutions of the Company’s board of directors dated September 20, 2018 relating to, among other things, the Registration Statement and the offering of the Offered Securities.
 
 
 
Gowling WLG (Canada) LLP
Suite 1600, 1 First Canadian Place
100 King Street West
Toronto ON M5X 1G5 Canada
 
T +1 416 862 7525
F +1 416 862 7661
gowlingwlg.com
 
Gowling WLG (Canada) LLP is a member of Gowling WLG, an international law firm which consists of independent and autonomous entities providing services around the world. Our structure is explained in more detail at gowlingwlg.com/legal.
 
 
 
Assumptions and Reliances
 
We have relied exclusively upon the certificates (including the Officer’s Certificate), documents and records we examined with respect to the accuracy of the factual matters contained in them and we have not performed any independent investigation or verification of those factual matters. We have assumed those factual matters were accurate on the date given and continue to be accurate as of the date of this opinion.
 
For the purposes of the opinions expressed below, we have assumed, without independent investigation or inquiry, that:
 
(a)
with respect to all documents and instruments examined by us, the signatures are genuine, the individuals signing those documents or instruments had legal capacity at the time of signing and, with respect to all parties to documents or instruments relevant hereto other than the Company, that such parties had the requisite power and authority (corporate or otherwise) to execute, deliver and perform such documents or instruments, that such documents or instruments have been duly authorized by all requisite action (corporate or otherwise) executed and delivered by such parties and that such documents or instruments are the legal, valid, binding and enforceable obligations of such parties, all documents or instruments submitted to us as originals are authentic, and certified, conformed or photocopied copies, or copies transmitted electronically or by facsimile, conform to the authentic original documents or instruments;
 
(b)
with respect to the Warrants, Pre-Funded Warrants and Wainwright Warrants, that such documents or instruments are the legal, valid, binding and enforceable obligations of the parties thereto, including the Company; and
 
(c)
the completeness and accuracy of the Company’s corporate records in our possession, and the indices and records in all filing systems maintained in all public offices where we have searched or inquired or have caused searches or inquiries to be conducted are accurate and current, and all certificates and information issued or provided under those searches or inquiries are and remain accurate and complete;
 
The opinions expressed in this opinion letter are limited to the Canadian federal laws and such laws of the Province of Ontario as are applicable to the Company as a Canadian corporation and should not be relied upon, nor are they given in respect of, the laws of any other jurisdiction.
 
Opinions
 
Based upon and subject to the foregoing, and subject to the further limitations, qualifications and assumptions stated herein, we are of the opinion that:
 
1. 
The sale of the Unit Shares has been duly authorized and, when such Unit Shares are duly issued and delivered against payment of the consideration therefor on terms as finally determined by the board of directors of the Company, such Unit Shares will be validly issued as fully paid and non-assessable shares in the capital of the Company.
 
2. 
The sale of the Warrants has been duly authorized and, when duly created, issued and sold on terms as finally determined by the board of directors of the Company, and upon the due exercise of such Warrants in accordance with their terms including the payment of the exercise price therefor, the Warrant Shares issuable thereby will be validly issued as fully paid and non-assessable shares in the capital of the Company.
 
3. 
The sale of the Pre-Funded Warrants has been duly authorized and, when duly created, issued and sold on terms as finally determined by the board of directors of the Company, and upon the due exercise of such Pre-Funded Warrants in accordance with their terms including the payment of the exercise price therefor, the Pre-Funded Warrant Shares issuable thereby will be validly issued as fully paid and non-assessable shares in the capital of the Company.
 
 
 
4. 
The issue of the Wainwright Warrants has been duly authorized and, when duly created and issued on terms as finally determined by the board of directors of the Company, and upon the due exercise of such Wainwright Warrants in accordance with their terms including the payment of the exercise price therefor, the Wainwright Warrant Shares issuable thereby will be validly issued as fully paid and non-assessable shares in the capital of the Company.
 
Qualifications and Limitations
 
The opinions express herein are subject to the following exceptions, qualifications and limitations: (a) the legality, validity, binding effect and enforceability of any agreement are subject to, and may be limited by, applicable bankruptcy, insolvency, reorganization, arrangement, winding-up, liquidation, moratorium, preference and other similar laws of general applicable affecting the enforcement of creditors’ rights generally; and (b) the enforceability of the obligations of the Company may be limited by general equitable and legal principles, including those relating to the conduct of parties such as reasonableness and good faith in the performance of contracts, and to the principle that equitable remedies such as injunctive relief and specific performance are only available in the discretion of the court.
 
Consent
 
We consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference to our name under the caption “Legal Matters” in the Prospectus forming part of the Registration Statement. In giving this consent, we do not thereby imply or admit that we come within the categories of persons whose consent is required by the Securities Act or the rules and regulations promulgated thereunder.
 
This opinion letter is expressly limited to the matters set forth above, and we render no opinion, whether by implication or otherwise, as to any other matters relating to the Company or the Offered Securities. This opinion letter is rendered as of the date first written above and we disclaim any obligation to advise you of facts, circumstances, events or developments which hereafter may be brought to our attention and which may alter, affect or modify the opinion expressed herein. We understand and agree that Buchanan Ingersoll & Rooney PC may rely on this opinion as if it were an addressee hereof for the purpose of providing the opinion to be delivered by such firm in connection with the Registration Statement.
 
Very truly yours,
 
/s/ Gowling WLG (Canada) LLP
 
 
 
Gowling WLG (Canada) LLP